arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Wave Life Sciences, Inc.

WVE Health Care Biotechnology: Pharmaceutical Preparations
$3.12
▼ -7.4% Today
as of Oct 23, 15:07 ET
Last 30 days -31.55% Sep 14 → Oct 23
$2.97 $3.40 $3.83 $4.27 $4.70 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.36
High
$3.43
Low
$3.34
Volume
$2M
Avg Vol
$4M
Mkt Cap
$765M
P/E (TTM)
—
Beta
—
52w High
$21.73
52w Low
$3.04
Div Yield
—
Shares Out
$193M

Recent Press Releases & News last 60 days · 17 items

Oct 22 · 03:02 MarketBeat
WAVE Life Sciences Highlights Obesity Data, FDA-Aligned RNA Editing Path
Oct 20 · 12:30 PR GlobeNewswire
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026
Oct 19 · 12:30 PR GlobeNewswire
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
▸ Show all 17 press releases & news Free account →

WVE earnings at a glance

The options market is pricing a move of about ±18.1% after the report, a range of roughly $2.56 to $3.68 from today's $3.12. Over its last 1 reports the stock rose the next day 1 time and fell 0, moving ±0.8% on average; after the most recent report on May 8, 2025 it moved +0.8%. That means options currently expect more movement than WVE has typically delivered. WVE beat the consensus EPS estimate in 0 of its last 3 reported quarters. Implied volatility is currently 153%. The share price of $3.12 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.04
$22
0% of range
Avg surprise (last 3)
-7.0%
Avg reaction (last 1)
+0.8%
100% positive
Latest IV / EM
153%
EM ±18.1% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.47$-0.33$-0.20$-0.06$0.07 Actual $-0.27Actual $-0.20Actual $0.07Actual $-0.24Actual $-0.25Actual $-0.47Actual $-0.29Est $-0.27Actual $-0.31Est $-0.29Actual $-0.32Est $-0.30Actual $-0.13Actual $-0.34 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025MarJun
Revenue vs Net Income Revenue Net income
$-69M$-42M$-15M$13M$40M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.34 — — — — financials
Tue Mar 31, 2026Mar 2026 $-0.13 — — — — financials
Mon Nov 10, 2025Sep/2025 $-0.32 $-0.30 -6.7% — — earnings
Wed Jul 30, 2025Jun/2025 $-0.31 $-0.29 -6.9% — — earnings
Thu May 8, 2025Mar/2025 $-0.29 $-0.27 -7.4% — +0.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.47 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.25 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.24 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.07 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.20 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.27 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$2M$38M——$9M$9M——
Cost of revenue————————
Gross profit————————
Operating income$-74M$-31M—$-56M$-53M$-50M—$-64M
Net income$-69M$-26M—$-54M$-50M$-47M—$-62M
EPS (diluted)$-0.34$-0.13—$-0.32$-0.31$-0.29—$-0.47

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$368M$545M$602M$196M$208M$243M$302M$311M
Inventory————————
Total current assets$508M$561M$615M$215M$224M$258M$320M$325M
Total assets$558M$584M$638M$241M$252M$288M$352M$359M
Long-term debt————————
Total liabilities$105M$72M$112M$109M$105M$109M$135M$209M
Total equity$454M$512M$518M$125M$139M$172M$210M$142M

Implied volatility — last 90 days

33%114%195%276%357% Jun 07 — IV 110% · EM ±15.3%Jun 08 — IV 107% · EM ±14.1%Jun 09 — IV 107% · EM ±13.4%Jun 10 — IV 136% · EM ±16.1%Jun 11 — IV 101% · EM ±11.2%Jun 12 — IV 127% · EM ±13.0%Jun 15 — IV 104% · EM ±7.5%Jun 16 — IV 246% · EM ±14.5%Jun 17 — IV 140% · EM ±5.8%Jun 19 — IV 70% · EM ±15.4%Jun 22 — IV 74% · EM ±15.4%Jun 23 — IV 93% · EM ±19.1%Jun 24 — IV 84% · EM ±16.8%Jun 25 — IV 113% · EM ±22.2%Jun 26 — IV 110% · EM ±21.0%Jun 29 — IV 119% · EM ±21.1%Jun 30 — IV 97% · EM ±16.8%Jul 01 — IV 98% · EM ±16.3%Jul 02 — IV 76% · EM ±12.3%Jul 03 — IV 79% · EM ±12.4%Jul 06 — IV 160% · EM ±22.2%Jul 07 — IV 140% · EM ±18.5%Jul 09 — IV 114% · EM ±13.5%Jul 13 — IV 227% · EM ±19.0%Jul 14 — IV 124% · EM ±9.0%Jul 15 — IV 244% · EM ±14.4%Jul 16 — IV 327% · EM ±13.7%Jul 21 — IV 87% · EM ±20.3%Jul 22 — IV 95% · EM ±21.8%Jul 23 — IV 125% · EM ±28.1%Jul 24 — IV 72% · EM ±15.9%Jul 27 — IV 95% · EM ±19.8%Jul 28 — IV 87% · EM ±17.9%Jul 29 — IV 77% · EM ±15.5%Jul 30 — IV 86% · EM ±16.9%Jul 31 — IV 90% · EM ±17.2%Aug 03 — IV 93% · EM ±16.6%Aug 04 — IV 75% · EM ±12.9%Aug 05 — IV 86% · EM ±14.3%Aug 06 — IV 95% · EM ±15.4%Aug 07 — IV 73% · EM ±11.5%Aug 10 — IV 104% · EM ±14.4%Aug 11 — IV 136% · EM ±18.0%Aug 12 — IV 91% · EM ±11.4%Aug 14 — IV 318% · EM ±35.1%Aug 19 — IV 297% · EM ±17.5%Aug 20 — IV 357% · EM ±14.9%Aug 24 — IV 37% · EM ±7.8%Aug 25 — IV 92% · EM ±18.9%Aug 26 — IV 33% · EM ±6.7%Aug 27 — IV 52% · EM ±10.2%Aug 28 — IV 36% · EM ±7.0%Aug 31 — IV 63% · EM ±11.2%Sep 01 — IV 85% · EM ±14.6%Sep 02 — IV 68% · EM ±11.4%Sep 03 — IV 63% · EM ±10.2%Sep 04 — IV 76% · EM ±11.8%Sep 07 — IV 85% · EM ±11.8%Sep 10 — IV 91% · EM ±10.7%Sep 11 — IV 148% · EM ±16.3%Sep 14 — IV 261% · EM ±21.8%Sep 21 — IV 115% · EM ±24.0%Sep 22 — IV 163% · EM ±33.4%Sep 23 — IV 155% · EM ±31.0%Sep 24 — IV 103% · EM ±20.2%Sep 25 — IV 152% · EM ±29.1%Sep 28 — IV 100% · EM ±17.7%Sep 29 — IV 132% · EM ±22.7%Oct 02 — IV 119% · EM ±18.5%Oct 05 — IV 103% · EM ±14.2%Oct 06 — IV 199% · EM ±26.3%Oct 07 — IV 113% · EM ±14.1%Oct 08 — IV 153% · EM ±18.1%

Sector peers

LXRX
Lexicon Pharmaceuticals, Inc.
$783M $1.39-11.2%
DSGN
Design Therapeutics, Inc.
$732M $10.21-4.9%
ESPR
Esperion Therapeutics, Inc.
$819M $3.18
MDXG
MiMedx Group, Inc
$672M $3.87+3.5%
NVCT
Nuvectis Pharma, Inc.
$662M $20.02-3.3%
HELP
Helus Pharma Inc.
$870M $10.18-5.6%

WVE earnings FAQ

What is WVE's expected move for earnings?

Options currently price a move of about ±18.1%, or $0.56 per share either way from $3.12.

How does WVE stock usually react to earnings?

Across the last 1 reports the average next-day move was ±0.8%, up 1 times and down 0 times.

What is WVE's implied volatility?

WVE's at-the-money implied volatility is about 153% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in